Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek – Cambr - Third market - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2017-10-03 19:39:44		Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek – Cambr Add to Reading List Source URL: visterrainc.com Download Document from Source Website File Size: 26,75 KB Share Document on Facebook